Cyclooxygenase inhibition by diclofenac formulated in bioadhesive carriers

Biochimica et Biophysica Acta - Biomembranes

Volumn 1778, Issue 4, 2008, Pages 931-936

  Elron Gross, Inbar ^a   Glucksam, Yifat ^a   Melikhov, Dina ^a   Margalit, Rimona ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Collagen; Cyclooxygenase; Diclofenac; Drug carriers; Hyaluronan; Osteoarthritis

Indexed keywords

ADHESIVE AGENT; CD44 HYALURONAN RECEPTOR; COLLAGEN; DICLOFENAC; DRUG CARRIER; HYALURONIC ACID; INTEGRIN; LIPOSOME; PROSTAGLANDIN SYNTHASE; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOPHYSICS; CELL LINE; CELL STRAIN COS7; CELL STRAIN HT29; CONTROLLED STUDY; DRUG FORMULATION; DRUG HALF LIFE; ENCAPSULATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECEPTOR AFFINITY; SUSTAINED DRUG RELEASE;

ADHESIVENESS; ANIMALS; ANTIBODIES; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DRUG CARRIERS; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; KINETICS; LIPOSOMES; MICE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 40949093027     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.01.002     Document Type: Article

References (30)

1. K.D. Brandt. Osteoarthritis, in: E. Braunwald, A.S. Fauci, D.L. Kasper, S.L. Hauser, D.L. Longo, J.L. Jameson (Eds.), Harrison's : Principles of internal medicine, Vol. 2, McGraw-Hill Professional Publishing; 15th edition. pp. 1987-1992.
2. Ge Z., Hu Y., Heng B.C., Yang Z., Ouyang H., Lee E.H., and Cao T. Osteoarthritis and therapy. Arthritis Rheum. 55 (2006) 493-500
3. Saravanan M., Bhaskar K., Maharajan G., and Pillai K.S. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres. Int. J. Pharm. 283 (2004) 71-82
4. Bove S.E., Calcaterra S.L., Brooker R.M., Huber C.M., Guzman R.E., Juneau P.L., Schrier D.J., and Kilgore K.S. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthr. Cartil. 11 (2003) 821-830
5. Sun S.F., Chou Y.J., Hsu C.W., Hwang C.W., Hsu P.T., Wang J.L., Hsu Y.W., and Chou M.C. Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthr. Cartil. 14 (2006) 867-874
6. Moreland L.W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis. Res. Ther. 5 (2003) 54-67
7. Towheed T.E. Pennsaid therapy for osteoarthritis of the knee: a systematic review and metaanalysis of randomized controlled trials. J. Rheumatol. 33 (2006) 567-573
8. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
9. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
10. Khazaeinia T., and Jamali F. Effect of drug release rate on therapeutic outcomes: formulation dependence of gastrointestinal toxicity of diclofenac in the rat. Inflammopharmacology 12 (2004) 69-80
11. Tsai M.F., Chiang Y.L., Wang L.F., Huang G.W., and Wu P.C. Oral sustained delivery of diclofenac sodium using calcium chondroitin sulfate matrix. J. Biomat. Sci. 16 (2006) 1319-1331
12. Cevc G., and Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta 1514 (2001) 191-205
13. Yerushalmi N., Arad A., and Margalit R. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. Arch Biochem Biophys 313 (1994) 267-273
14. Yerushalmi N., and Margalit R. Bioadhesive, collagen-modified liposomes: molecular and cellular level studies on the kinetics of drug release and on binding to cell monolayers. Biochim. Biophys. Acta 1189 (1994) 13-20
15. Yerushalmi N., and Margalit R. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites. Arch. Biochem. Biophys. 349 (1998) 21-26
16. Carraway K.L., and Koshland D.E. Carbodiimide modification of proteins. Methods Enzymol. 25 (1972) 616-623
17. Weissing V., Lasch J., and Gregoriadis G. Covalent coupling of sugars to liposomes. Biochem. Biophys. Acta. 1003 (1989) 54-57
18. Margalit R. Liposome-mediated drug targeting in topical and regional therapies. Crit. Rev. Ther. Drug.Carrier Syst. 12 (1995) 233-261
19. Peer D., and Margalit R. Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes. Arch. Biochem. Biophys. 383 (2000) 185-190
20. Fischer S., Arad A., and Margalit R. Lipsome-formulated enzymes for organophosphate scavenging: butyrylcholinesterase and Demeton-S. Arch. Biochem. Biophys. 434 (2005) 108-115
21. Peer D., and Margalit R. Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia 6 (2004) 343-353
22. Dedhar S., Ruoslahti E., and Pierschbacher M.D. A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence. J. Cell. Biol. 104 (1987) 585-593
23. Isacke C.M., and Yarwood H. The hyaluronan receptor, CD44. Int. J. Biochem. Cell. Biol. 34 (2002) 718-721
24. White D.J., Puranen S., Johnson M.S., and Heino J. The collagen receptor subfamily of the integrins. Int. J. Biochem. Cell. Biol. 36 (2004) 1405-1410
25. Toole B.P. Hyaluronan: from extracellular glue to pericellular cure. Nat. Rev. Cancer 4 (2004) 528-539
26. Peer D., and Margalit R. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int. J. Cancer 108 (2004) 780-789
27. Peer D., Florentin A., and Margalit R. Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes. Biochim. Biophys. Acta 1612 (2003) 76-82
28. Margalit R. Liposomal drug delivery: thermodynamic and chemical kinetic consideration. J. Cont. Rel. 17 (1991) 285-296
29. Margalit R. Bioadhesive Liposomes for Topical Treatment of Wounds. In: Chohen S.B., and Bernstein H. (Eds). Microparticulate Systems for the Delivery of Protein and Vaccines vol. 77 (1996), CRC press 425-461
30. Levin G., Kariv N., Khomiak E., and Raz A. Indomethacin inhibits the accumulation of tumor cells in mouse lungs and subsequent growth of lung metastases. Chemotherapy 46 (2000) 429-437